Last update 20 Jun 2024

VTP-195183

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AGN 195183, AGN-195183, IRX 5183
+ [4]
Target
Mechanism
RARα agonists(Retinoic acid receptor alpha agonists)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-

Structure

Molecular FormulaC22H22ClF2NO4
InChIKeyPNAWUIKCVQSLFG-UHFFFAOYSA-N
CAS Registry367273-07-2

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Promyelocytic LeukemiaPhase 2
US
01 Apr 2008
NeutropeniaPhase 2
AU
15 Oct 2005
Breast CancerPhase 2
US
13 Nov 2002
NeoplasmsPhase 2
US
05 Jul 2002
Stem cell mobilisationPhase 2
AU
--
Chronic Myelomonocytic LeukemiaPhase 1
US
30 Jan 2017
Myelodysplastic SyndromesPhase 1
US
30 Jan 2017
Refractory acute myeloid leukemiaPhase 1
US
30 Jan 2017
Relapsing acute myeloid leukemiaPhase 1
US
30 Jan 2017
Multiple MyelomaPreclinical
US
10 Jul 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
11
andnmnfffe(jqggslkxtu) = cAE included hypertriglyceridemia, fatigue, dyspnea, and edema. 3 pts at the first dose level developed asymptomatic Grade 3 hypertriglyceridemia veocnqskdz (meuwnnhfyp )
Positive
23 Oct 2020
Phase 1
15
gmfixspfza(mutixfgkpv) = 2 of 4 pts treated had gr 3 elevation of alkaline phosphatase yymwwleazx (wswgcmkcpw )
Positive
15 Jul 2004
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free